{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:28:36Z","timestamp":1761708516726,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.revmed.2009.12.008","type":"journal-article","created":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T04:51:10Z","timestamp":1272689470000},"page":"403-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["L\u2019aphtose r\u00e9currente\u00a0: innocuit\u00e9 du thalidomide \u00e0 faible dose"],"prefix":"10.1016","volume":"31","author":[{"given":"H.","family":"Gil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Dupond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Meaux-Ruault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hafsaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Limat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Magy-Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2009.12.008_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMcp054630","article-title":"Aphthous ulceration","volume":"355","author":"Scully","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.12.008_bib2","doi-asserted-by":"crossref","unstructured":"International Study Group for Beh\u00e7et's Disease. Criteria for diagnosis of Beh\u00e7et's disease. Lancet 1990;335:1078\u201380.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"10.1016\/j.revmed.2009.12.008_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0300-5089(21)00451-X","article-title":"Oral manifestations of inflammatory bowel disease","volume":"9","author":"Basu","year":"1980","journal-title":"Clin Gastroenterol"},{"key":"10.1016\/j.revmed.2009.12.008_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ajhp\/58.1.41","article-title":"Treatment strategies for recurrent oral aphthous ulcers","volume":"58","author":"Barrons","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.revmed.2009.12.008_bib5","first-page":"1365","article-title":"Aphtose buccale r\u00e9cidivante\u00a0: traitement par colchicine. \u00c9tude ouverte de 54\u00a0cas","volume":"129","author":"Fontes","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2009.12.008_bib6","first-page":"96","article-title":"The treatment of a case of recurrent oral aphthosis with pentoxifylline","volume":"192","author":"Pizarro","year":"1993","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.revmed.2009.12.008_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(85)70014-X","article-title":"Significant response of oral aphthosis to thalidomide treatment","volume":"12","author":"Grinspan","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2009.12.008_bib8","unstructured":"Protocole d\u2019utilisation th\u00e9rapeutique. Pharmion d\u00e9veloppement. D\u00e9cembre 2007."},{"key":"10.1016\/j.revmed.2009.12.008_bib9","first-page":"393","article-title":"Treatment of recurrent oro-genital ulceration with low doses of thalidomide","volume":"17","author":"de Wazi\u00e8res","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2009.12.008_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1979.04010050060027","article-title":"Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis","volume":"115","author":"Mascaro","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2009.12.008_bib11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archderm.1982.01650230003002","article-title":"Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis","volume":"118","author":"Torras","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2009.12.008_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2009.12.008_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2009.12.008_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000246279","article-title":"Thalidomide and recurrent aphthous stomatitis: a follow-up study","volume":"193","author":"Bonnetblanc","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.revmed.2009.12.008_bib15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","article-title":"Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses","volume":"35","author":"Tseng","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2009.12.008_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1523-1747.2002.19502.x","article-title":"Incidence and risk factors for thalidomide neuropathy: a prospective study of dermatologic patients","volume":"119","author":"Bastuji-Garin","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2009.12.008_bib17","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:26:22Z","timestamp":1759335982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866310001098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0248866310001098"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2009.12.008","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L\u2019aphtose r\u00e9currente\u00a0: innocuit\u00e9 du thalidomide \u00e0 faible dose","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2009.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}